These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 30825266)

  • 41. The Pathogenic Effect of Cortactin Tyrosine Phosphorylation in Cutaneous Squamous Cell Carcinoma.
    Zhu L; Cho E; Zhao G; Roh MR; Zheng Z
    In Vivo; 2019; 33(2):393-400. PubMed ID: 30804117
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Overexpression and Implications of Melanoma-associated Antigen A12 in Pathogenesis of Human Cutaneous Squamous Cell Carcinoma.
    Zhao G; Bae JY; Zheng Z; Park HS; Chung KY; Roh MR; Jin Z
    Anticancer Res; 2019 Apr; 39(4):1849-1857. PubMed ID: 30952725
    [TBL] [Abstract][Full Text] [Related]  

  • 43. LINC00460 Promotes Cutaneous Squamous Cell Carcinoma Progression Through Stabilizing ELAVL1 Protein.
    Xue C; Yang Z; Yang B; Xiong H; Ye W
    Mol Biotechnol; 2023 Aug; 65(8):1296-1305. PubMed ID: 36513874
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MicroRNA-31 is overexpressed in cutaneous squamous cell carcinoma and regulates cell motility and colony formation ability of tumor cells.
    Wang A; Landén NX; Meisgen F; Lohcharoenkal W; Ståhle M; Sonkoly E; Pivarcsi A
    PLoS One; 2014; 9(7):e103206. PubMed ID: 25068518
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HOTAIR/Sp1/miR-199a critically regulates cancer stemness and malignant progression of cutaneous squamous cell carcinoma.
    Chen J; Hou SF; Tang FJ; Liu DS; Chen ZZ; Zhang HL; Wang SH
    Oncogene; 2022 Jan; 41(1):99-111. PubMed ID: 34697449
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Complement factor I promotes progression of cutaneous squamous cell carcinoma.
    Riihilä P; Nissinen L; Farshchian M; Kivisaari A; Ala-Aho R; Kallajoki M; Grénman R; Meri S; Peltonen S; Peltonen J; Kähäri VM
    J Invest Dermatol; 2015 Feb; 135(2):579-588. PubMed ID: 25184960
    [TBL] [Abstract][Full Text] [Related]  

  • 47. KLF9 (Kruppel Like Factor 9) induced PFKFB3 (6-Phosphofructo-2-Kinase/Fructose-2, 6-Biphosphatase 3) downregulation inhibits the proliferation, metastasis and aerobic glycolysis of cutaneous squamous cell carcinoma cells.
    Xing J; Jia Z; Xu Y; Chen M; Yang Z; Chen Y; Han Y
    Bioengineered; 2021 Dec; 12(1):7563-7576. PubMed ID: 34612136
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MicroRNA-1 down-regulates proliferation and migration of breast cancer stem cells by inhibiting the Wnt/β-catenin pathway.
    Liu T; Hu K; Zhao Z; Chen G; Ou X; Zhang H; Zhang X; Wei X; Wang D; Cui M; Liu C
    Oncotarget; 2015 Dec; 6(39):41638-49. PubMed ID: 26497855
    [TBL] [Abstract][Full Text] [Related]  

  • 49. LncRNA NEF inhibits migration and invasion of HPV-negative cervical squamous cell carcinoma by inhibiting TGF-β pathway.
    Ju W; Luo X; Zhang N
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30910843
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epigenetic Regulation of iASPP-p63 Feedback Loop in Cutaneous Squamous Cell Carcinoma.
    Robinson DJ; Patel A; Purdie KJ; Wang J; Rizvi H; Hufbauer M; Ostano P; Akgül B; Chiorino G; Harwood CA; Bergamaschi D
    J Invest Dermatol; 2019 Aug; 139(8):1658-1671.e8. PubMed ID: 30710576
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long Noncoding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity.
    Piipponen M; Nissinen L; Farshchian M; Riihilä P; Kivisaari A; Kallajoki M; Peltonen J; Peltonen S; Kähäri VM
    J Invest Dermatol; 2016 Aug; 136(8):1701-1710. PubMed ID: 27049681
    [TBL] [Abstract][Full Text] [Related]  

  • 52. miR-365 promotes cutaneous squamous cell carcinoma (CSCC) through targeting nuclear factor I/B (NFIB).
    Zhou M; Zhou L; Zheng L; Guo L; Wang Y; Liu H; Ou C; Ding Z
    PLoS One; 2014; 9(6):e100620. PubMed ID: 24949940
    [TBL] [Abstract][Full Text] [Related]  

  • 53. USF1-induced upregulation of LINC01048 promotes cell proliferation and apoptosis in cutaneous squamous cell carcinoma by binding to TAF15 to transcriptionally activate YAP1.
    Chen L; Chen Q; Kuang S; Zhao C; Yang L; Zhang Y; Zhu H; Yang R
    Cell Death Dis; 2019 Apr; 10(4):296. PubMed ID: 30931936
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Knockdown of Nav1.5 inhibits cell proliferation, migration and invasion via Wnt/β-catenin signaling pathway in oral squamous cell carcinoma.
    Xu X; Dai Y; Feng L; Zhang H; Hu Y; Xu L; Zhu X; Jiang Y
    Acta Biochim Biophys Sin (Shanghai); 2020 May; 52(5):527-535. PubMed ID: 32400862
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MiR-130a Acts as a Tumor Suppressor MicroRNA in Cutaneous Squamous Cell Carcinoma and Regulates the Activity of the BMP/SMAD Pathway by Suppressing ACVR1.
    Lohcharoenkal W; Li C; Das Mahapatra K; Lapins J; Homey B; Sonkoly E; Pivarcsi A
    J Invest Dermatol; 2021 Aug; 141(8):1922-1931. PubMed ID: 33766507
    [TBL] [Abstract][Full Text] [Related]  

  • 56. LncRNA, TUG1 regulates the oral squamous cell carcinoma progression possibly via interacting with Wnt/β-catenin signaling.
    Liang S; Zhang S; Wang P; Yang C; Shang C; Yang J; Wang J
    Gene; 2017 Apr; 608():49-57. PubMed ID: 28119088
    [TBL] [Abstract][Full Text] [Related]  

  • 57. C3a and C5a receptor antagonists ameliorate endothelial-myofibroblast transition via the Wnt/β-catenin signaling pathway in diabetic kidney disease.
    Li L; Chen L; Zang J; Tang X; Liu Y; Zhang J; Bai L; Yin Q; Lu Y; Cheng J; Fu P; Liu F
    Metabolism; 2015 May; 64(5):597-610. PubMed ID: 25682062
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Role of long noncoding RNA MALAT1 promotes the occurrence and progression of cutaneous squamous cell carcinoma].
    Li SS; Zhou L; Gao L; Wang YH; Ding ZH
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Apr; 38(4):421-427. PubMed ID: 29735442
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Wnt1 and SFRP1 as potential prognostic factors and therapeutic targets in cutaneous squamous cell carcinoma.
    Halifu Y; Liang JQ; Zeng XW; Ding Y; Zhang XY; Jin TB; Yakeya B; Abudu D; Zhou YM; Liu XM; Hu FX; Chai L; Kang XJ
    Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27420949
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SOST silencing promotes proliferation and invasion and reduces apoptosis of retinoblastoma cells by activating Wnt/β-catenin signaling pathway.
    Wu T; Wang LN; Tang DR; Sun FY
    Gene Ther; 2017 Jul; 24(7):399-407. PubMed ID: 28485721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.